You searched for: giraza (Rumänska - Engelska)

adn - giraza joacă un rol crucial în acest proces.
the enzyme dna-gyrase plays a crucial role in this process.

ciprofloxacina inhibă adn- giraza, determinând inhibarea sintezei adn.
ciprofloxacin inhibits dna-gyrase, resulting in inhibition of dna synthesis.

principalele ţinte ale pradofloxacinei sunt enzimele adn giraza şi topoizomeraza iv.
the primary targets for pradofloxacin are the bacterial dna gyrase and topoisomerase iv enzymes.

enzima adn- giraza joacă un rol crucial în acest proces.
the enzyme dna-gyrase plays a crucial role in this process.

ciprofloxacina inhibă adn- giraza, determinând inhibarea sintezei adn- ului.
ciprofloxacin inhibits dna-gyrase, resulting in inhibition of dna synthesis.

asocierea reversibilă dintre pradofloxacină şi adn giraza sau adn topoizomeraza iv în bacteriile ţintă determină inhibarea acestor enzime şi moartea rapidă a celulei bacteriene.
reversible association between pradofloxacin and dna gyrase or dna topoisomerase iv in the target bacteria results in inhibition of these enzymes and rapid death of the bacterial cell.

medicamentul acţionează prin blocarea unei enzime numite „adn-giraza” care este importantă deoarece permite bacteriilor să-şi multiplice propriul adn.
it works by blocking an enzyme called ‘dna gyrase’, which is important in allowing bacteria to make copies of their dna.

fiind un medicament din grupa fluorochinolonelor antibacteriene, acţiunea bactericidă a ciprofloxacinei este rezultatul inhibării atât a topoizomerazei de tip ii (adn- giraza), cât şi a
as a fluoroquinolone antibacterial agent, the bactericidal action of ciprofloxacin results from the inhibition of both type ii topoisomerase (dna-gyrase) and topoisomerase iv, required for bacterial dna replication, transcription, repair and recombination.

fiind un medicament din grupa fluorochinolonelor antibacteriene, acţiunea bactericidă a ciprofloxacinei este rezultatul inhibării atât a topoizomerazei de tip ii (adn- giraza), cât şi a topoizomerazei iv, necesară pentru replicarea, transcripţia, repararea şi recombinarea adn- ului bacterian.
as a fluoroquinolone antibacterial agent, the bactericidal action of ciprofloxacin results from the inhibition of both type ii topoisomerase (dna-gyrase) and topoisomerase iv, required for bacterial dna replication, transcription, repair and recombination.